A few individuals are believed to have developed immune thrombocytopenia (ITP) following the administration of the coronavirus disease 2019 (COVID-19) vaccine. This phenomenon has been reported in a few case reports and also in some recent news articles. In this report, we discuss a case of a 54-year-old Caucasian female who presented to the emergency room with life-threatening thrombocytopenia in the setting of de novo ITP following COVID-19 vaccine administration. Due to the relapsing nature of ITP, it is unclear if the patient has achieved complete remission of the disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657 | PMC |
| http://dx.doi.org/10.7759/cureus.14853 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 vaccine
12
vaccine administration
8
newly diagnosed
4
diagnosed idiopathic
4
idiopathic thrombocytopenia
4
thrombocytopenia post
4
post covid-19
4
administration individuals
4
individuals believed
4
believed developed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!